OUR WORK

Learn More

Learn More

BRANDING AND LOGO DEVELOPMENT

Our client had a critical need to motivate clinicians and patients to participate in a clinical trial targeting a tough to treat blood cancer. Working in concert with the client team, Medallion developed the logo and visual voice to motivate clinicians and patients to seek participation in this important clinical trial with the expectation of a good outcome. Expecting a good outcome is often not the case with AML patients who are FLT3 positive, but this product will offer another option for those reaching for another milestone.

Early Market Research.

We were contacted by a small up and coming biotech company seeking to carve out a place in the growing world of immuno-oncology. Understanding the importance of differentiating its novel platform from other potential market players, the client asked Medallion to uncover its current perception and how its messages were being received in the marketplace. Medallion quickly engaged a cross-section of experts and delivered refined and ranked messages to implement in a series of targeted events. We listened. We responded. We delivered.

THOUGHT-LEADER Profiles.

At Medallion, we believe Thought-Leader development is a critical organizational competency for organizations looking to accelerate uptake of their products and maximize return through good drug development and life-cycle planning. We have developed the proprietary Strategic Thought-Leader Engagement Pathway “The STEP MODEL” which is designed to help companies build a customized list of physicians and other key players to ensure they engage with the right external experts.   Thought-leader profiles are a key deliverable from the STEP model and a critical tool for reference in developing thought-leaders.

Heat Maps.

Clients often times have a need to measure their relationship with thought-leaders either for internal tracking or versus their competitors.  Medallion deep relationships permit the creation of very detailed and interactive heat maps which combine public information with deep organizational insight.  These have proven to be a very valuable tool for clients seeking to establish or maintain leadership in the Oncology marketplace.

Syndicated Reports

Medallion Healthcare leverages its database to execute and publish the results of an annual Thought-Leader (TL) survey which assesses the most impactful TL’s in the United States.  This insights and influence report captures regional and national thought-leaders in the United States from the perspective of community oncologists.  The report also explores the key influences on physician decision-making and why thought-leaders are considered thought-leaders. The core tumors covered include Breast, Lung, Prostate and Colon.

 

• Identify the most influential TL’s in the US through the eyes of community physicians

• Identify the most impactful sources of information as it relates to changing physician behaviors

• Determine the perceived impact of pharmaceutical companies influence

• Asses physician perceptions of most effective companies at engaging with TL’s

• Syndicated Questions permitted

 

COMPETITIVE INTELLIGENCE.

Working in collaboration with OBR, Medallion has participated in the creation of one of the world’s most powerful, oncology specific, completive intelligence tracking tools. This product monitors thought leaders, utilizing the Medallion Insights and Influence report to identify the top Thought-Leaders and OBR personnel to track key activities. Taking advantage of the first Oncology News aggregation service. OBR, subscribers receive the latest Oncology news and information along with updates on policy changes, stocks, and key radar events such as PDUFA dates and approvals. As a bonus, each day has a streaming video from the OBR video center which houses real-time commentary from some of the most respected physicians in the world. Each user has a unique login and can customize their competitive basket for tracking products and companies.

© Medallion Healthcare 2021. All rights reserved